InvestorsHub Logo
icon url

groverdongles

06/08/21 4:54 PM

#6319 RE: Skiluc #6317

Granted. But they had no choice but to raise the A/S to be able to pay off this note. They'll also need to raise money to conduct clinical trials, if in fact Escozine is approved for IND status. We might see more noteholders if it does get approved. But there's no hiding it, they are diluting. But they do at least have decent reasons to raise capital.
icon url

Dragon Lady

06/08/21 6:00 PM

#6340 RE: Skiluc #6317

AND "ON_TRACK_TO_HEAR_FROM_FDA_IND_AROUND_JUNE_15th" = POSITIVE !

They WOULD NOT speak about it in a confident tone - this close to that date (literally one week) if they were not confident of GOOD NEWS aka in no way, shape or form have they heard "bad or negative feedback" from their FDA IND case manager = STELLAR !!


EVEN IF the FDA comes back with a "We'd like a bit more data here and one tweak on this and that" = STILL GOOD as the FDA is working as a team with them and WILL GET THE IND ACROSS THE FINISH LINE - that is how the "process" works when PROS ARE DOING IT -

And when one looks at this new Chief Science Officer's pedigree and background he is HEAVILY "FDA SUBMISSION EXPERIENCES" and has Harvard med to his name and 65 peer reviewed journal articles - this ain't the dude's first FDA IND rodeo submission :)

GOOD CALL TODAY ON UPDATES - and I'm 100% convinced now MORE THAN EVER to expect a CORP NAME CHANGE and SYMBOL CHANGE as they could not even trademark the Qnta legacy products - and aren't really even that interested in doing so.

They're laying ALL NEW GROUND all new BRANDING - and that's because this is an ENTIRE NEW COMPANY POST MERGER !!

PATIENCE FOLKS - the new Sr Mgt team has literally only been in full charge like 30 days and is just warming their chairs - but THEY SAID "IN ORDER TO UPLIST TO THE NASDAQ WHERE WE FEEL WE BELONG" as to why they got the reverse split just "in the hopper" as a "tool" and now any massive dilution bullshit.

EXAMPLE: Lets say this thing gets to a $BUCK A SHARE in a few months and EASILY when they bag the FDA IND - and they now get some real serious investors wanting to put in say $10 million non dilutive financing.

Would shareholders accept a 1 for 10 reverse split to $10 a share IF IF IF it means you own a NASDAQ TRADED RAPID GROWTH COMPANY NOW ???

I sure as hell know what I'd do - I'd buy more hand over fist. OTC uplists are rare and RUN LIKE HELL ON JUST THE ANNOUNCEMENT BEING MADE - and these dude's IMO are not the usual hype n crap talkers- I really believe they "know" they have the goods and sales growth and pedigree to get there - ESPECIALLY ON THE FDA IND being granted then all bets are off as to how high this goes -

AND ON THE IND APPROVAL - they get INSTANT Dominican and ALL OF LATIN AMERICA "approval" to sell ESQOZINE as a CANCER and likely COVID treatment - but cancer alone "BY medical doctor's prescribing it" = $20 million or more in sales very, very rapidly !!

QNTA - and WHAT IS THE NEW CORP NAME AND NEW SYMBOL NOW :)